Holo Technologies SL

Based in Spain, Holo Technologies SL offers advanced health monitoring solutions through comprehensive biomarker testing, empowering individuals to manage their health proactively and make informed lifestyle choices. Holo Technologies SL specializes in health monitoring services through biomarker analysis. Founded in 2025 in Tarragona, Spain, the company has completed 1 deal. In November 2025, it raised EUR 1 million in its pre-seed funding round, co-led by Calm/Storm Ventures and Mission Ventures, with participation from Enisa.

The founder's background is not detailed, and the company does not operate as a subsidiary of another entity. Holo offers advanced health monitoring services through its core product, which involves comprehensive biomarker testing. The company provides two primary testing plans: the Core plan, which evaluates over 110 biomarkers, and the Starter plan, which focuses on 80 essential biomarkers. These tests are designed to track an individual's health indicators, enabling users to gain insights into their physical state and make informed lifestyle choices.

The testing process is streamlined, requiring only a simple blood and urine sample collected at convenient lab locations. Holo's services cater to health-conscious individuals seeking proactive management of their health and wellness, leveraging technology to integrate tracking from wearables and personal health data. The company operates primarily within the European market, with a focus on countries that prioritize preventative healthcare and personal wellness solutions. Holo generates revenue through a subscription model that allows customers to access its biomarker testing services and ongoing health monitoring.

Clients can choose between the Core and Starter plans, with prices starting at EUR 199 for the initial testing services. Revenue is structured around individual test payments, with additional fees possibly incurred for extended services or more specialized tests. The transaction model is direct to consumer, enabling users to manage their subscriptions and track their health data through Holo's app. Each customer receives personalized Clinician Notes and an Action Plan based on their test results, fostering ongoing engagement and support in their health journey.

Holo’s focus on prevention and detailed health insights positions it uniquely within the health tech industry, appealing to a growing market of consumers invested in maintaining their vitality. In November 2025, Holo Technologies SL raised EUR 1 million in pre-seed funding to enhance its platform, add new medical services, and support partnerships with European clinics. The company plans to expand its offerings by developing new products aimed at improving health outcomes and is focused on entering additional European markets by 2026.